134 related articles for article (PubMed ID: 6891949)
41. Experimental and clinical studies on the intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers.
Furukawa T; Kumai K; Kubota T; Hirahata S; Shimizu H; Matsui H; Takahara T; Aizawa K; Shibata S; Shimada A
Surg Today; 1993; 23(4):298-306. PubMed ID: 8318783
[TBL] [Abstract][Full Text] [Related]
42. Cisplatin tumor concentrations after intra-arterial cisplatin infusion or embolization in patients with oral cancer.
Tegeder I; Bräutigam L; Seegel M; Al-Dam A; Turowski B; Geisslinger G; Kovács AF
Clin Pharmacol Ther; 2003 May; 73(5):417-26. PubMed ID: 12732842
[TBL] [Abstract][Full Text] [Related]
43. Comparison of the pharmacokinetics of ultrafilterable cisplatin species detectable by derivatization with diethyldithiocarbamate or atomic absorption spectroscopy.
Goel R; Andrews PA; Pfeifle CE; Abramson IS; Kirmani S; Howell SB
Eur J Cancer; 1990 Jan; 26(1):21-7. PubMed ID: 2156545
[TBL] [Abstract][Full Text] [Related]
44. [Chemotherapy for advanced bladder cancer: clinical evaluation of chemotherapy for locally advanced or metastatic bladder cancer and adjuvant chemotherapy for deeply invasive bladder cancer following radical cystectomy].
Uekado Y; Ogawa T; Yoshida T; Yamamoto S; Hirano A; Watanabe T; Shinka T; Ohkawa T
Hinyokika Kiyo; 1985 Aug; 31(8):1365-70. PubMed ID: 3841260
[TBL] [Abstract][Full Text] [Related]
45. Effect of coadministration of selenite on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II) given repeatedly to mice.
Satoh M; Naganuma A; Imura N
Cancer Chemother Pharmacol; 1992; 30(6):439-43. PubMed ID: 1394800
[TBL] [Abstract][Full Text] [Related]
46. The enhanced therapeutic efficacy of intra-arterial cis-diamminedichloroplatinum (II) chemotherapy in combination with aortic clamping on metastatic hepatic tumors in the rat.
Nishioka Y
Surg Today; 1994; 24(2):128-32. PubMed ID: 8054790
[TBL] [Abstract][Full Text] [Related]
47. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
de Jong WH; Steerenberg PA; Vos JG; Bulten EJ; Verbeek F; Kruizinga W; Ruitenberg EJ
Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993
[TBL] [Abstract][Full Text] [Related]
48. Sodium thiosulfate fails to increase the therapeutic index of intravenously administered cis-diamminedichloroplatinum (II) in mice bearing murine and human tumors.
Aamdal S; Fodstad O; Pihl A
Cancer Chemother Pharmacol; 1988; 21(2):129-33. PubMed ID: 3349560
[TBL] [Abstract][Full Text] [Related]
49. Transplacental carcinogenesis by cisplatin in F344/NCr rats: promotion of kidney tumors by postnatal administration of sodium barbital.
Diwan BA; Anderson LM; Ward JM; Henneman JR; Rice JM
Toxicol Appl Pharmacol; 1995 May; 132(1):115-21. PubMed ID: 7747274
[TBL] [Abstract][Full Text] [Related]
50. [Intrahepatic-artery infusion of cis-diamminedichloroplatinum (II) and 5-fluorouracil in primary or metastatic liver cancer].
Koga S; Maeta M; Wakatsuki T; Ikeda Y; Inoue Y; Ishiguro M
Gan To Kagaku Ryoho; 1987 Feb; 14(2):404-10. PubMed ID: 3813571
[TBL] [Abstract][Full Text] [Related]
51. cis-diamminedichloroplatinum(II)-induced sister-chromatid exchanges and chromosome aberration formation in cultured human lymphocytes and their inhibition by sodium thiosulfate.
Ohe T; Tsuda S; Sakata Y; Taniwaki M; Misawa S; Abe T
Mutat Res; 1990 Aug; 244(4):279-85. PubMed ID: 2385243
[TBL] [Abstract][Full Text] [Related]
52. [Therapy of peritoneal carcinosis with intraperitoneal administration of cis-diamminedichloroplatinum and systemic sodium thiosulfate protection. Clinical results of a pilot study and pharmacokinetics].
Ehninger G; Rückle H; Haag C; Wilms K
Onkologie; 1985 Aug; 8(4):202-6. PubMed ID: 3912689
[TBL] [Abstract][Full Text] [Related]
53. "Two-route chemotherapy" using high-dose intra-arterial neocarzinostatin and systemic tiopronin, its antidote, for rat limb tumor.
Iwamoto Y; Kuroiwa T; Aoki K; Baba T
Cancer Chemother Pharmacol; 1986; 17(3):247-50. PubMed ID: 2943525
[TBL] [Abstract][Full Text] [Related]
54. Selenium-induced protection against cis-diamminedichloroplatinum(II) nephrotoxicity in mice and rats.
Baldew GS; van den Hamer CJ; Los G; Vermeulen NP; de Goeij JJ; McVie JG
Cancer Res; 1989 Jun; 49(11):3020-3. PubMed ID: 2720662
[TBL] [Abstract][Full Text] [Related]
55. Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastases.
Civalleri D; Esposito M; Fulco RA; Vannozzi M; Balletto N; De Cian F; Percivale PL; Merlo F
Cancer; 1991 Sep; 68(5):988-94. PubMed ID: 1913493
[TBL] [Abstract][Full Text] [Related]
56. Percutaneous hepatic arterial infusion of cisplatin for metastatic breast cancer.
Fraschini G; Fleishman G; Yap HY; Carrasco CH; Charnsangavej C; Patt YZ; Hortobagyi GN
Cancer Treat Rep; 1987 Mar; 71(3):313-5. PubMed ID: 3815396
[TBL] [Abstract][Full Text] [Related]
57. The pharmacology of hepatic regional administration of cisplatin in a rabbit model.
Kar R; Opfell RW; Wile AG
Cancer Drug Deliv; 1987; 4(4):225-32. PubMed ID: 3454249
[TBL] [Abstract][Full Text] [Related]
58. [Clinical study of the effect of cisplatin therapy in unresectable hepatocellular carcinoma].
Matsuki S; Sugimoto M; Nii S; Kokubu S; Yamada N; Ishii K; Shibata H; Okabe H
Gan To Kagaku Ryoho; 1988 Jan; 15(1):53-7. PubMed ID: 2827586
[TBL] [Abstract][Full Text] [Related]
59. Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer.
Robbins KT; Storniolo AM; Kerber C; Vicario D; Seagren S; Shea M; Hanchett C; Los G; Howell SB
J Clin Oncol; 1994 Oct; 12(10):2113-20. PubMed ID: 7931481
[TBL] [Abstract][Full Text] [Related]
60. [Two route infusion therapy of cisplatin using balloon catheter for primary liver cancer--with special reference to its provisional effects and side effects].
Onohara S; Sonoda T; Oyama T; Kobayashi H; Uchiyama N; Yamaguchi K; Shinohara S
Nihon Igaku Hoshasen Gakkai Zasshi; 1984 May; 44(5):700-6. PubMed ID: 6435092
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
